Share Price and Basic Stock Data
Last Updated: February 3, 2026, 2:10 am
| PEG Ratio | 2.27 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fineotex Chemical Ltd operates in the specialty chemicals sector, primarily focusing on the production of textile chemicals. The company reported a market capitalization of ₹2,558 Cr and a share price of ₹21.9. Over the past fiscal year, Fineotex has demonstrated robust revenue growth, with sales rising from ₹368 Cr in March 2022 to ₹517 Cr in March 2023. The trailing twelve months (TTM) sales stood at ₹520 Cr, indicating a slight decline in the most recent fiscal year to ₹533 Cr in March 2025. Quarterly sales figures also reflect this trend, with the latest reported sales of ₹145 Cr in September 2023, up from ₹134 Cr in September 2022. Despite fluctuations, the overall trajectory shows a significant increase in sales compared to earlier years, with operating profit margins (OPM) maintaining a healthy average of approximately 23%. This performance underscores Fineotex’s ability to capitalize on growing demand in the specialty chemicals market.
Profitability and Efficiency Metrics
Fineotex Chemical Ltd has consistently reported solid profitability metrics, with a net profit of ₹99 Cr and an impressive return on equity (ROE) of 18.4%. The company’s operating profit margins (OPM) stood at 23%, reflecting efficient cost management and pricing strategies. Profit before tax for the fiscal year ending March 2025 was recorded at ₹141 Cr, down from ₹158 Cr in March 2024, indicating a slight contraction in profitability. However, the interest coverage ratio (ICR) of 141.76x highlights Fineotex’s strong ability to meet its interest obligations, supported by zero borrowings. The cash conversion cycle (CCC) was reported at 88 days, suggesting efficient inventory and receivables management. The company’s net profit margin of 20.47% further emphasizes its capability to convert revenue into profit effectively, which is favorable when compared to sector norms.
Balance Sheet Strength and Financial Ratios
Fineotex Chemical Ltd exhibits a robust balance sheet, characterized by total reserves of ₹756 Cr and no borrowings, highlighting a debt-free status. This financial strength is complemented by a current ratio of 3.89, indicating strong liquidity to cover short-term obligations. The company’s book value per share increased significantly to ₹63.83 in March 2025 from ₹40.95 in March 2024. The total assets of ₹878 Cr reflect a well-capitalized structure that supports its operational needs. The firm has maintained a return on capital employed (ROCE) of 24%, illustrating effective utilization of capital. Furthermore, the price-to-book value (P/BV) ratio stood at 3.60x, which, while higher than typical sector levels, suggests a premium valuation reflecting market confidence in future growth potential. Overall, these figures present a favorable financial stability outlook for Fineotex, despite the high equity valuation metrics.
Shareholding Pattern and Investor Confidence
The shareholding structure of Fineotex Chemical Ltd reveals a strong commitment from its promoters, who hold 62.57% of the company. This level of promoter holding is indicative of confidence in the company’s future prospects. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have modest stakes of 2.53% and 1.28%, respectively, reflecting cautious interest from institutional investors. The public shareholding accounted for 33.63%, with the total number of shareholders rising to 165,512, indicating increasing retail interest. Over recent quarters, promoter holdings have slightly decreased, which could suggest strategic divestments or capital raising efforts. The overall stability in the shareholding pattern, alongside increasing public participation, enhances investor confidence, although the decreasing stake of promoters could raise questions about long-term commitment.
Outlook, Risks, and Final Insight
Looking ahead, Fineotex Chemical Ltd is poised for continued growth, underpinned by its strong financial metrics and market position. The absence of debt, coupled with robust profitability ratios, positions the company favorably in a competitive landscape. However, potential risks include fluctuations in raw material costs and market demand, which could impact margins and sales. Additionally, the high P/BV ratio may deter value-focused investors, as it suggests the stock is trading at a premium. The company’s ability to maintain its operational efficiency and profit margins will be crucial in navigating these challenges. Overall, Fineotex’s strategic focus on expanding its product portfolio and enhancing operational efficiencies could lead to sustainable growth, provided it effectively manages the associated risks inherent in the chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 345 Cr. | 37.6 | 71.2/35.0 | 21.5 | 20.5 | 1.06 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 30.1 Cr. | 61.4 | 88.8/52.0 | 14.4 | 89.6 | 1.63 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 44.3 Cr. | 651 | 899/600 | 20.4 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,222 Cr. | 71.1 | 111/68.2 | 21.3 | 22.0 | 0.70 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 544 Cr. | 218 | 377/208 | 19.6 | 93.8 | 1.15 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,622.28 Cr | 683.84 | 58.37 | 182.97 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 134 | 109 | 138 | 132 | 145 | 138 | 153 | 142 | 146 | 126 | 120 | 137 | 138 |
| Expenses | 109 | 81 | 105 | 101 | 107 | 98 | 115 | 107 | 109 | 92 | 99 | 112 | 107 |
| Operating Profit | 25 | 29 | 33 | 32 | 38 | 40 | 38 | 35 | 36 | 34 | 21 | 25 | 31 |
| OPM % | 19% | 26% | 24% | 24% | 26% | 29% | 25% | 25% | 25% | 27% | 18% | 18% | 23% |
| Other Income | 2 | 2 | 2 | 4 | 4 | 5 | 4 | 5 | 7 | 5 | 8 | 9 | 8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 |
| Profit before tax | 26 | 29 | 33 | 34 | 40 | 44 | 40 | 38 | 41 | 36 | 26 | 31 | 35 |
| Tax % | 21% | 23% | 22% | 22% | 22% | 24% | 24% | 22% | 21% | 24% | 24% | 21% | 26% |
| Net Profit | 21 | 22 | 26 | 26 | 31 | 33 | 30 | 29 | 32 | 28 | 20 | 25 | 26 |
| EPS in Rs | 0.19 | 0.20 | 0.23 | 0.23 | 0.28 | 0.29 | 0.27 | 0.26 | 0.28 | 0.24 | 0.17 | 0.22 | 0.23 |
Last Updated: January 1, 2026, 7:36 pm
Below is a detailed analysis of the quarterly data for Fineotex Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 138.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Jun 2025) to 138.00 Cr., marking an increase of 1.00 Cr..
- For Expenses, as of Sep 2025, the value is 107.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 112.00 Cr. (Jun 2025) to 107.00 Cr., marking a decrease of 5.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Jun 2025) to 31.00 Cr., marking an increase of 6.00 Cr..
- For OPM %, as of Sep 2025, the value is 23.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Jun 2025) to 23.00%, marking an increase of 5.00%.
- For Other Income, as of Sep 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Jun 2025) to 8.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Jun 2025) to 35.00 Cr., marking an increase of 4.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Jun 2025) to 26.00%, marking an increase of 5.00%.
- For Net Profit, as of Sep 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Jun 2025) to 26.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.23. The value appears strong and on an upward trend. It has increased from 0.22 (Jun 2025) to 0.23, marking an increase of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 87 | 102 | 110 | 127 | 141 | 182 | 196 | 219 | 368 | 517 | 569 | 533 | 520 |
| Expenses | 77 | 85 | 82 | 98 | 111 | 148 | 162 | 178 | 297 | 404 | 421 | 406 | 409 |
| Operating Profit | 9 | 16 | 28 | 29 | 30 | 34 | 35 | 41 | 71 | 113 | 148 | 127 | 112 |
| OPM % | 11% | 16% | 26% | 23% | 21% | 19% | 18% | 19% | 19% | 22% | 26% | 24% | 21% |
| Other Income | 3 | 5 | 2 | 10 | 5 | 1 | -11 | 17 | 6 | 7 | 17 | 24 | 29 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 10 |
| Profit before tax | 11 | 20 | 29 | 38 | 34 | 34 | 22 | 56 | 73 | 115 | 158 | 141 | 130 |
| Tax % | 30% | 28% | 31% | 24% | 29% | 28% | 35% | 20% | 22% | 22% | 23% | 23% | |
| Net Profit | 8 | 15 | 20 | 29 | 24 | 24 | 14 | 45 | 57 | 90 | 121 | 109 | 99 |
| EPS in Rs | 0.06 | 0.11 | 0.16 | 0.23 | 0.20 | 0.20 | 0.12 | 0.38 | 0.50 | 0.80 | 1.08 | 0.94 | 0.86 |
| Dividend Payout % | 9% | 9% | 13% | 4% | 10% | 5% | 4% | 8% | 8% | 10% | 15% | 8% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 87.50% | 33.33% | 45.00% | -17.24% | 0.00% | -41.67% | 221.43% | 26.67% | 57.89% | 34.44% | -9.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | -54.17% | 11.67% | -62.24% | 17.24% | -41.67% | 263.10% | -194.76% | 31.23% | -23.45% | -44.36% |
Fineotex Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 22% |
| 3 Years: | 13% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 40% |
| 3 Years: | 25% |
| TTM: | -15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 50% |
| 3 Years: | -13% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 24% |
| 3 Years: | 24% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 4:00 am
Balance Sheet
Last Updated: December 4, 2025, 1:14 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 23 | 23 |
| Reserves | 54 | 54 | 69 | 90 | 113 | 137 | 147 | 187 | 240 | 327 | 425 | 708 | 756 |
| Borrowings | 4 | 2 | 3 | 1 | 5 | 2 | 3 | 3 | 2 | 7 | 5 | 0 | 0 |
| Other Liabilities | 19 | 23 | 20 | 26 | 21 | 34 | 35 | 54 | 75 | 67 | 96 | 83 | 98 |
| Total Liabilities | 88 | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 815 | 878 |
| Fixed Assets | 14 | 18 | 19 | 27 | 29 | 36 | 41 | 59 | 84 | 99 | 141 | 179 | 198 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 0 | 0 | 21 | 8 |
| Investments | 16 | 29 | 39 | 47 | 55 | 48 | 52 | 32 | 17 | 89 | 147 | 330 | 348 |
| Other Assets | 58 | 54 | 56 | 66 | 77 | 110 | 114 | 171 | 238 | 234 | 260 | 284 | 323 |
| Total Assets | 88 | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 815 | 878 |
Below is a detailed analysis of the balance sheet data for Fineotex Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
- For Reserves, as of Sep 2025, the value is 756.00 Cr.. The value appears strong and on an upward trend. It has increased from 708.00 Cr. (Mar 2025) to 756.00 Cr., marking an increase of 48.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 98.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 83.00 Cr. (Mar 2025) to 98.00 Cr., marking an increase of 15.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 878.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 815.00 Cr. (Mar 2025) to 878.00 Cr., marking an increase of 63.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 198.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2025) to 198.00 Cr., marking an increase of 19.00 Cr..
- For CWIP, as of Sep 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 348.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2025) to 348.00 Cr., marking an increase of 18.00 Cr..
- For Other Assets, as of Sep 2025, the value is 323.00 Cr.. The value appears strong and on an upward trend. It has increased from 284.00 Cr. (Mar 2025) to 323.00 Cr., marking an increase of 39.00 Cr..
- For Total Assets, as of Sep 2025, the value is 878.00 Cr.. The value appears strong and on an upward trend. It has increased from 815.00 Cr. (Mar 2025) to 878.00 Cr., marking an increase of 63.00 Cr..
Notably, the Reserves (756.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 5.00 | 14.00 | 25.00 | 28.00 | 25.00 | 32.00 | 32.00 | 38.00 | 69.00 | 106.00 | 143.00 | 127.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 80 | 84 | 84 | 72 | 98 | 100 | 138 | 110 | 72 | 89 | 79 |
| Inventory Days | 68 | 56 | 66 | 70 | 97 | 84 | 66 | 79 | 98 | 53 | 55 | 75 |
| Days Payable | 81 | 75 | 75 | 82 | 50 | 70 | 73 | 101 | 96 | 53 | 79 | 66 |
| Cash Conversion Cycle | 79 | 60 | 75 | 72 | 119 | 112 | 93 | 116 | 111 | 72 | 64 | 88 |
| Working Capital Days | 80 | 58 | 73 | 73 | 114 | 118 | 107 | 136 | 125 | 71 | 76 | 104 |
| ROCE % | 15% | 21% | 31% | 35% | 26% | 22% | 20% | 28% | 30% | 36% | 39% | 24% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 14,829,218 | 0.05 | 36.57 | 17,788,190 | 2025-12-15 03:04:08 | -16.63% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 9.53 | 10.82 | 7.97 | 4.97 | 3.84 |
| Diluted EPS (Rs.) | 9.53 | 10.82 | 7.97 | 4.97 | 3.84 |
| Cash EPS (Rs.) | 10.34 | 11.47 | 8.47 | 5.36 | 4.16 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 63.83 | 40.95 | 32.12 | 24.32 | 19.51 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 63.83 | 40.95 | 32.12 | 24.32 | 19.51 |
| Revenue From Operations / Share (Rs.) | 46.55 | 51.37 | 46.68 | 33.25 | 19.73 |
| PBDIT / Share (Rs.) | 13.23 | 14.89 | 10.83 | 6.93 | 5.24 |
| PBIT / Share (Rs.) | 12.42 | 14.35 | 10.44 | 6.70 | 5.11 |
| PBT / Share (Rs.) | 12.33 | 14.23 | 10.37 | 6.62 | 5.04 |
| Net Profit / Share (Rs.) | 9.53 | 10.93 | 8.09 | 5.14 | 4.02 |
| NP After MI And SOA / Share (Rs.) | 9.44 | 10.82 | 7.97 | 4.98 | 3.85 |
| PBDIT Margin (%) | 28.41 | 28.98 | 23.19 | 20.83 | 26.57 |
| PBIT Margin (%) | 26.68 | 27.92 | 22.36 | 20.15 | 25.89 |
| PBT Margin (%) | 26.48 | 27.69 | 22.20 | 19.90 | 25.56 |
| Net Profit Margin (%) | 20.47 | 21.27 | 17.32 | 15.44 | 20.39 |
| NP After MI And SOA Margin (%) | 20.28 | 21.05 | 17.08 | 14.98 | 19.49 |
| Return on Networth / Equity (%) | 14.79 | 26.79 | 25.32 | 21.04 | 20.34 |
| Return on Capital Employeed (%) | 19.03 | 34.63 | 32.21 | 27.34 | 26.03 |
| Return On Assets (%) | 13.28 | 21.85 | 20.89 | 16.25 | 15.94 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.78 | 1.17 | 1.36 | 1.21 | 0.61 |
| Current Ratio (X) | 3.89 | 3.20 | 3.51 | 3.41 | 3.30 |
| Quick Ratio (X) | 2.93 | 2.64 | 2.77 | 2.53 | 2.72 |
| Inventory Turnover Ratio (X) | 9.31 | 6.98 | 6.37 | 4.92 | 3.46 |
| Dividend Payout Ratio (NP) (%) | 4.23 | 18.48 | 5.01 | 6.02 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3.90 | 17.60 | 4.78 | 5.75 | 0.00 |
| Earning Retention Ratio (%) | 95.77 | 81.52 | 94.99 | 93.98 | 0.00 |
| Cash Earning Retention Ratio (%) | 96.10 | 82.40 | 95.22 | 94.25 | 0.00 |
| Interest Coverage Ratio (X) | 141.76 | 123.87 | 146.13 | 83.11 | 80.21 |
| Interest Coverage Ratio (Post Tax) (X) | 103.17 | 91.90 | 110.15 | 62.62 | 62.55 |
| Enterprise Value (Cr.) | 2598.43 | 4052.88 | 2534.05 | 1965.68 | 704.98 |
| EV / Net Operating Revenue (X) | 4.87 | 7.12 | 4.90 | 5.34 | 3.23 |
| EV / EBITDA (X) | 17.15 | 24.57 | 21.13 | 25.62 | 12.14 |
| MarketCap / Net Operating Revenue (X) | 4.94 | 7.17 | 4.99 | 5.42 | 3.34 |
| Retention Ratios (%) | 95.76 | 81.51 | 94.98 | 93.97 | 0.00 |
| Price / BV (X) | 3.60 | 9.13 | 7.40 | 7.61 | 3.48 |
| Price / Net Operating Revenue (X) | 4.94 | 7.17 | 4.99 | 5.42 | 3.34 |
| EarningsYield | 0.04 | 0.02 | 0.03 | 0.02 | 0.05 |
After reviewing the key financial ratios for Fineotex Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.53. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.53, marking a decrease of 1.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.53. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.53, marking a decrease of 1.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.34. This value is within the healthy range. It has decreased from 11.47 (Mar 24) to 10.34, marking a decrease of 1.13.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.83. It has increased from 40.95 (Mar 24) to 63.83, marking an increase of 22.88.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.83. It has increased from 40.95 (Mar 24) to 63.83, marking an increase of 22.88.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.55. It has decreased from 51.37 (Mar 24) to 46.55, marking a decrease of 4.82.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 13.23. This value is within the healthy range. It has decreased from 14.89 (Mar 24) to 13.23, marking a decrease of 1.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 12.42. This value is within the healthy range. It has decreased from 14.35 (Mar 24) to 12.42, marking a decrease of 1.93.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.33. This value is within the healthy range. It has decreased from 14.23 (Mar 24) to 12.33, marking a decrease of 1.90.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.53. This value is within the healthy range. It has decreased from 10.93 (Mar 24) to 9.53, marking a decrease of 1.40.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.44. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.44, marking a decrease of 1.38.
- For PBDIT Margin (%), as of Mar 25, the value is 28.41. This value is within the healthy range. It has decreased from 28.98 (Mar 24) to 28.41, marking a decrease of 0.57.
- For PBIT Margin (%), as of Mar 25, the value is 26.68. This value exceeds the healthy maximum of 20. It has decreased from 27.92 (Mar 24) to 26.68, marking a decrease of 1.24.
- For PBT Margin (%), as of Mar 25, the value is 26.48. This value is within the healthy range. It has decreased from 27.69 (Mar 24) to 26.48, marking a decrease of 1.21.
- For Net Profit Margin (%), as of Mar 25, the value is 20.47. This value exceeds the healthy maximum of 10. It has decreased from 21.27 (Mar 24) to 20.47, marking a decrease of 0.80.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 20.28. This value exceeds the healthy maximum of 20. It has decreased from 21.05 (Mar 24) to 20.28, marking a decrease of 0.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.79. This value is below the healthy minimum of 15. It has decreased from 26.79 (Mar 24) to 14.79, marking a decrease of 12.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.03. This value is within the healthy range. It has decreased from 34.63 (Mar 24) to 19.03, marking a decrease of 15.60.
- For Return On Assets (%), as of Mar 25, the value is 13.28. This value is within the healthy range. It has decreased from 21.85 (Mar 24) to 13.28, marking a decrease of 8.57.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 1.17 (Mar 24) to 0.78, marking a decrease of 0.39.
- For Current Ratio (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 3.20 (Mar 24) to 3.89, marking an increase of 0.69.
- For Quick Ratio (X), as of Mar 25, the value is 2.93. This value exceeds the healthy maximum of 2. It has increased from 2.64 (Mar 24) to 2.93, marking an increase of 0.29.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.31. This value exceeds the healthy maximum of 8. It has increased from 6.98 (Mar 24) to 9.31, marking an increase of 2.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.23. This value is below the healthy minimum of 20. It has decreased from 18.48 (Mar 24) to 4.23, marking a decrease of 14.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 20. It has decreased from 17.60 (Mar 24) to 3.90, marking a decrease of 13.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.77. This value exceeds the healthy maximum of 70. It has increased from 81.52 (Mar 24) to 95.77, marking an increase of 14.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.10. This value exceeds the healthy maximum of 70. It has increased from 82.40 (Mar 24) to 96.10, marking an increase of 13.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 141.76. This value is within the healthy range. It has increased from 123.87 (Mar 24) to 141.76, marking an increase of 17.89.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 103.17. This value is within the healthy range. It has increased from 91.90 (Mar 24) to 103.17, marking an increase of 11.27.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,598.43. It has decreased from 4,052.88 (Mar 24) to 2,598.43, marking a decrease of 1,454.45.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.87. This value exceeds the healthy maximum of 3. It has decreased from 7.12 (Mar 24) to 4.87, marking a decrease of 2.25.
- For EV / EBITDA (X), as of Mar 25, the value is 17.15. This value exceeds the healthy maximum of 15. It has decreased from 24.57 (Mar 24) to 17.15, marking a decrease of 7.42.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has decreased from 7.17 (Mar 24) to 4.94, marking a decrease of 2.23.
- For Retention Ratios (%), as of Mar 25, the value is 95.76. This value exceeds the healthy maximum of 70. It has increased from 81.51 (Mar 24) to 95.76, marking an increase of 14.25.
- For Price / BV (X), as of Mar 25, the value is 3.60. This value exceeds the healthy maximum of 3. It has decreased from 9.13 (Mar 24) to 3.60, marking a decrease of 5.53.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has decreased from 7.17 (Mar 24) to 4.94, marking a decrease of 2.23.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fineotex Chemical Ltd:
- Net Profit Margin: 20.47%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.03% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.79% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 103.17
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.93
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26 (Industry average Stock P/E: 58.37)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.47%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | 42 & 43, Manorama Chambers, Mumbai Maharashtra 400050 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Surendrakumar Tibrewala | Chairman & Managing Director |
| Mr. Sanjay Tibrewala | Executive Director & CFO |
| Mrs. Aarti Jhunjhunwala | Executive Director |
| Mrs. Bindu Shah | Independent Director |
| Dr. Sunil Waghmare | Independent Director |
| Mr. Alok Dhanuka | Independent Director |
| Mr. Navin Mittal | Independent Director |
| Dr. Amit Prabhakar Pratap | Independent Director |
FAQ
What is the intrinsic value of Fineotex Chemical Ltd?
Fineotex Chemical Ltd's intrinsic value (as of 06 February 2026) is ₹29.11 which is 32.92% higher the current market price of ₹21.90, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,558 Cr. market cap, FY2025-2026 high/low of ₹35.8/19.2, reserves of ₹756 Cr, and liabilities of ₹878 Cr.
What is the Market Cap of Fineotex Chemical Ltd?
The Market Cap of Fineotex Chemical Ltd is 2,558 Cr..
What is the current Stock Price of Fineotex Chemical Ltd as on 06 February 2026?
The current stock price of Fineotex Chemical Ltd as on 06 February 2026 is ₹21.9.
What is the High / Low of Fineotex Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fineotex Chemical Ltd stocks is ₹35.8/19.2.
What is the Stock P/E of Fineotex Chemical Ltd?
The Stock P/E of Fineotex Chemical Ltd is 26.0.
What is the Book Value of Fineotex Chemical Ltd?
The Book Value of Fineotex Chemical Ltd is 6.80.
What is the Dividend Yield of Fineotex Chemical Ltd?
The Dividend Yield of Fineotex Chemical Ltd is 0.37 %.
What is the ROCE of Fineotex Chemical Ltd?
The ROCE of Fineotex Chemical Ltd is 23.8 %.
What is the ROE of Fineotex Chemical Ltd?
The ROE of Fineotex Chemical Ltd is 18.4 %.
What is the Face Value of Fineotex Chemical Ltd?
The Face Value of Fineotex Chemical Ltd is 1.00.